Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
250.85
DKK
-2.73%
Market Closed
Market Cap:
kr1.1T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novo Nordisk A/S
CSE:NOVO B
|
DK |
|
U
|
US Ecology Inc
F:3ER
|
US |
|
ICICI Lombard General Insurance Company Ltd
NSE:ICICIGI
|
IN |
|
Naipu Mining Machinery Co Ltd
SZSE:300818
|
CN |
|
Litian Pictures Holdings Ltd
HKEX:9958
|
CN |
|
J
|
Jinling Pharmaceutical Co Ltd
SZSE:000919
|
CN |
|
HanesBrands Inc
NYSE:HBI
|
US |
|
G
|
Guangdong Taienkang Pharmaceutical Co Ltd
SZSE:301263
|
CN |
Multiples-Based Value
The
Multiples-Based Value for
Novo Nordisk A/S (NOVO B)
under the Base Case is
hidden
DKK.
Compared with the current market price of 250.85 DKK, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NOVO B Multiples-Based Value
LOCKED
Multiples Across Competitors
NOVO B Competitors Multiples
Novo Nordisk A/S Competitors
Novo Nordisk A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8 | 9.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869.1B USD | 13.1 | 41.3 | 28 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
555.5B USD | 5.7 | 25.9 | 16.6 | 21.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.2 | 19.8 | 11.7 | 13.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.8B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226.8B CHF | 4.9 | 19.9 | 12.3 | 15.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 4.3 | 15.3 | 9.5 | 11.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.5B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
84.9B GBP | 2.6 | 14.8 | 8.1 | 10 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
